SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-15-114403
Filing Date
2015-03-31
Accepted
2015-03-31 17:15:15
Documents
16
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d900336d10k.htm 10-K 704592
2 EX-10.4.1 d900336dex1041.htm EX-10.4.1 25320
3 EX-21.1 d900336dex211.htm EX-21.1 1874
4 EX-23.1 d900336dex231.htm EX-23.1 1656
5 EX-31.1 d900336dex311.htm EX-31.1 6829
6 EX-31.2 d900336dex312.htm EX-31.2 6983
7 EX-32.1 d900336dex321.htm EX-32.1 3440
8 EX-32.2 d900336dex322.htm EX-32.2 3564
15 GRAPHIC g900336image001.jpg GRAPHIC 39437
16 GRAPHIC g900336snap0146.jpg GRAPHIC 3585
  Complete submission text file 0001193125-15-114403.txt   5196900

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT qhoi-20141231.xml EX-101.INS 431350
10 XBRL TAXONOMY EXTENSION SCHEMA qhoi-20141231.xsd EX-101.SCH 58180
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qhoi-20141231_cal.xml EX-101.CAL 41479
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qhoi-20141231_def.xml EX-101.DEF 132881
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE qhoi-20141231_lab.xml EX-101.LAB 709383
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qhoi-20141231_pre.xml EX-101.PRE 350185
Mailing Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108
Business Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108 (801) 582-5400
Q Therapeutics, Inc. (Filer) CIK: 0001366541 (see all company filings)

IRS No.: 203708500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52062 | Film No.: 15740331
SIC: 2834 Pharmaceutical Preparations